Last updated: 17 June 2026
How much does the Wegovy pill cost?
Currently, the Wegovy pill is priced starting at £129 per month. We also offer a £30 discount for your first order. The MHRA approved oral Wegovy for sale in the UK in June 2026.
How much does the Wegovy injection cost in the UK?
Wegovy injections start from £99 through Simple Online Pharmacy. You will find similar pricing across other GLP-1 treatments. Mounjaro and Wegovy cost and stock UK pricing sit in a similar band.
Wegovy pill pricing is currently comparable to the Wegovy injection, and increases with the dose in the same way.
What you pay will depend on your prescribed dose and choice of provider, plus any offers available. In the UK, private prescriptions include 20% VAT, and pharmacies set their own prices on top of the cost of the medicine from Novo Nordisk.
Will the Wegovy pill be cheaper than the injection?
Currently, the Wegovy pill starts at £129 per month. However, we are offering a £30 discount for your first order, bringing the price down to £99.
Not at the moment. Novo Nordisk has set UK pricing for the pill at a similar level to the injection, so there is no cost saving from switching formats right now.
That could change. Producing tablets costs less than producing injectable pens. Tablets do not need to be kept cold from manufacturer through to your letterbox and do not need a costly pen device. If Novo Nordisk passes those manufacturing savings on, the price of the pill could drop over time. We have no information on whether or when that will happen, so time will tell.
The bigger question is not which format costs less, but whether you can keep up with the Wegovy pill monthly cost. When the cost is a stretch, treatment becomes stop-start. People skip doses. They space doses out to make it last longer. Others stop for a few months, put weight back on, and come back to start again.
Wegovy only works if you take it consistently. It reduces your appetite, lowers blood sugar levels after meals, and helps you feel fuller for longer. Skip doses, and those effects fade. Stop altogether, and the weight may come back. That cycle of losing, stopping, and regaining is not just frustrating. It wears people down.
If the Wegovy pill cost per month drops in the future, more people will be able to stick with treatment long term. Whether the Wegovy pill is cheaper than the injection later down the line will depend on how Novo Nordisk adjusts its pricing over time.
Can I get the Wegovy pill on the NHS?
Not yet — the MHRA approved the Wegovy pill in June 2026, but NHS access requires a separate step. NICE reviews whether it works well enough and is affordable enough for the NHS to fund it. That review typically adds six to twelve months to the process. Realistically, it will be 2027 at the earliest for NHS access.
Wegovy weight loss injections are already available via the NHS, but only through specialist weight management services. Eligibility criteria are strict. You take it alongside a healthy diet and exercise, and treatment is capped at two years. The Wegovy pill on the NHS will likely follow a similar pathway once NICE completes its review.
What about the new cardiovascular guidance?
If you have existing heart disease and a BMI of 27 or above, NICE now recommends semaglutide to reduce your risk of further heart attacks and/or strokes. The SELECT trial showed it can reduce the risk by roughly 20%. The trial looked at adults without type 2 diabetes, though Wegovy is already used in patients with diabetes under separate guidance.
The NICE guidance was published in May 2026. Around 1.2 million people in England could become eligible for Wegovy on the NHS as a result. It currently covers the injection only, but now that the pill has MHRA approval, it could follow the same route.
Pre-order now
How do I get the Wegovy pill privately?
The Wegovy pill is available in the UK via private prescription, following MHRA approval in June 2026. You can buy Wegovy pill treatment in the UK through our online service at Simple Online Pharmacy.
In terms of how to get a Wegovy pill prescription, the process is an online clinical consultation. You submit your details, and one of our UK-registered prescribers reviews them. We check whether GLP-1 treatment is safe and right for you, not just whether you meet the BMI criteria.
The most common reasons we do not prescribe include: a personal or family history of medullary thyroid cancer (MTC) or Multiple Endocrine Neoplasia type 2 (MEN 2), active pancreatitis, pregnancy, or a BMI below the prescribing threshold. If we cannot prescribe treatment to you, we will let you know why and advise you to speak to your GP about other options.
If you currently take the 2.4mg Wegovy injection, the pill could be an option for you. It contains the same active ingredient in a different format. Pricing is currently comparable, so the decision is a practical one rather than a cost one.
The practical side of the switch depends on two things. Can you manage a strict daily fasting routine before your first food or drink? And have you been on your current dose long enough for your body to have adjusted?
When should I see a doctor?
Speak to our clinical team or your GP before starting any weight loss medication. We review your medical history, current medications, and overall health before prescribing.
Contact us or your GP if:
- You are unsure whether you meet the eligibility criteria for a Wegovy prescription
- Cost is stopping you from starting or continuing treatment. Your GP can talk through NHS options or alternative medications
- You take other medications and want to check for interactions
- You have a history of pancreatitis, thyroid problems, or gallbladder disease
The common side effects of Wegovy are stomach-related: nausea, diarrhoea, constipation, and vomiting. Most people find these settle as the body adjusts. If you have persistent nausea, vomiting that will not stop, or severe stomach pain, contact us. Do not push through those symptoms without clinical advice.
Dial 999 if you experience swelling of the face, lips, or throat, or difficulty breathing. These are signs of an allergic reaction and require immediate attention.
Key takeaways
- The Wegovy pill pricing has now been set at £129 for the first month. We also offer patients a discount of £30 on their first order, bringing the price down to £99
- Wegovy injection cost in the UK: £150 to £300 per month privately. NHS list price for the 2.4mg dose: £175.80 per month.
- The MHRA is expected to approve Wegovy tablets in late 2026. In clinical trials, people taking the daily pill saw an average weight loss of around 14% of their body weight. NHS availability is unlikely before 2027.
- New NICE cardiovascular guidance could widen NHS semaglutide access to around 1.2 million people. Currently, for the Wegovy injection only.
References
Semaglutide for managing overweight and obesity (TA875), National Institute for Health and Care Excellence, 2023 [Accessed 22 April 2026]
Semaglutide for reducing the risk of major adverse cardiovascular events in people with cardiovascular disease and overweight or obesity (GID-TA11544), National Institute for Health and Care Excellence, 2026 [Accessed 22 April 2026]
Semaglutide and cardiovascular outcomes in obesity without diabetes (SELECT), New England Journal of Medicine, 2023 [Accessed 22 April 2026]
Oral semaglutide 25 mg in adults with overweight or obesity (OASIS 4), New England Journal of Medicine, 2025 [Accessed 22 April 2026]
Weight regain and cardiometabolic effects after withdrawal of semaglutide: the STEP 1 trial extension, Diabetes, Obesity and Metabolism, 2022 [Accessed 22 April 2026]
NHS prescription charges, NHS, 2023 [Accessed 22 April 2026]
Semaglutide for reducing the risk of major adverse cardiovascular events in people with cardiovascular disease and overweight or obesity (TA1152), National Institute for Health and Care Excellence, May 2026 [Accessed 16 June 2026]
First GLP-1 tablet for weight loss approved in the UK, Medicines and Healthcare products Regulatory Agency, 2026 [Accessed 16 June 2026].
Wegovy 25 mg tablets – Summary of Product Characteristics, electronic medicines compendium (eMC), 2026 [Accessed 17 June 2026].
Authorship

Authored by Shereen Amin
Pharmacist Independent Prescriber & Medical Writer
GPhC: 2073003
Shereen is a Pharmacist Independent Prescriber and medical writer with over ten years' experience across NHS primary care, digital health and specialist services. She writes evidence-based health content for Simple Online Pharmacy, turning complex clinical information into guidance patients can actually use.
Medically Reviewed by Zahra Qureshi
Senior Pharmacist
GPhC: 2216331
Zahra began her pharmacy career in community pharmacy, building a strong foundation in patient care and medication safety. She joined Simple Online Pharmacy as a locum pharmacist and quickly progressed to a senior role, supporting the pharmacy and operations teams. Zahra is passionate about ensuring patient guidance is safe, clinically sound, and easy to understand, making a positive difference to patients’ lives.